Acute myeloid leukemia is a cancer that starts in the bone marrow, but most often moves into the blood. The fast track label is a process to expedite the review of drugs to treat serious conditions and fill an unmet medical need.
The biopharmaceutical company's shares were up almost 6.0% in recent trading.
Price: 2.41, Change: +0.13, Percent Change: +5.95
|Research Alert: CFRA Keeps Buy Opinion On Shares Of ...|
|Insider Sell: Velodyne Lidar|
|Insider Buy: Re/max Holdings|
|BGC Partners Updates Q2 Revenue Outlook|
|Unum Group Chief Accounting Officer Cherie Pashley t...|